Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)

PURPOSE: Fibroblast growth factor (FGF) signals are important in carcinogenesis and progression of prostate cancer. Dovitinib is an oral, pan-class inhibitor of vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor, and fibroblast growth factor receptor (FGFR)....

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yoon Ji, Kim, Hye Sook, Park, Se Hoon, Kim, Bong-Seog, Kim, Kyoung Ha, Lee, Hyo Jin, Song, Hong Suk, Shin, Dong-Yeop, Lee, Ha Young, Kim, Hoon-Gu, Lee, Kyung Hee, Lee, Jae Lyun, Park, Kyong Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192917/
https://www.ncbi.nlm.nih.gov/pubmed/29334610
http://dx.doi.org/10.4143/crt.2017.438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192917/
https://www.ncbi.nlm.nih.gov/pubmed/29334610
http://dx.doi.org/10.4143/crt.2017.438

Ejemplares similares